CTI BioPharma Corp. (CTIC)
Jun 26, 2023 - CTIC was delisted (reason: acquired by Sobi)
9.09
0.00 (0.00%)
Inactive · Last trade price on Jun 23, 2023

CTI BioPharma Revenue

CTI BioPharma had revenue of $24.12M in the quarter ending March 31, 2023, with 950.81% growth. This brings the company's revenue in the last twelve months to $75.77M, up 3,201.48% year-over-year. In the year 2022, CTI BioPharma had annual revenue of $53.95M.

Revenue (ttm)
$75.77M
Revenue Growth
+3,201.48%
P/S Ratio
15.82
Revenue / Employee
$596,606
Employees
127
Market Cap
1.20B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202253.95M--
Dec 31, 20210--
Dec 31, 20200--
Dec 31, 20193.35M-22.95M-87.28%
Dec 31, 201826.29M1.14M4.55%
Dec 31, 201725.15M-32.26M-56.20%
Dec 31, 201657.41M41.29M256.20%
Dec 31, 201516.12M-43.96M-73.17%
Dec 31, 201460.08M25.40M73.24%
Dec 31, 201334.68M--
Dec 31, 20120--
Dec 31, 20110--
Dec 31, 2010319.00K239.00K298.75%
Dec 31, 200980.00K-11.35M-99.30%
Dec 31, 200811.43M11.31M8,901.57%
Dec 31, 2007127.00K47.00K58.75%
Dec 31, 200680.00K-16.01M-99.50%
Dec 31, 200516.09M-13.50M-45.62%
Dec 31, 200429.59M4.83M19.50%
Dec 31, 200324.77M7.87M46.57%
Dec 31, 200216.90M10.66M170.94%
Dec 31, 20016.24M5.73M1,142.23%
Dec 31, 2000502.00K--
Dec 31, 19990--
Dec 31, 199813.20M1.37M11.57%
Dec 31, 199711.83M2.71M29.72%
Dec 31, 19969.12M9.02M9,020.81%
Dec 31, 1995100.00K--
Dec 31, 19940--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.